A supervised program before scheduled surgery
This single-blind randomized trial involved patients awaiting scheduled coronary, valve or aortic surgery. Their mean age was 66.5 years, and 44% were women.
The researchers assigned 24 patients to a program combining twice-weekly sessions of respiratory physiotherapy, muscle strengthening and health education. The other 12 formed the control group and used an incentive spirometer. The exact duration of the program is not specified in the available abstract.
Assessments were conducted before surgery and one week after hospital discharge. They included the six-minute walk test, respiratory muscle strength, frailty, grip strength and quality of life.
A targeted benefit, not proven overall recovery
The only statistically significant difference between the groups concerned maximal expiratory pressure, an indicator of the strength of the muscles used to breathe out. Its decline was greater in the control group. The program may therefore have reduced this loss rather than increased respiratory strength.
However, the authors report no improvement in functional capacity. The abstract does not provide absolute expiratory pressure values that would allow a concrete assessment of the size of the benefit.
Frailty increased significantly in the control group, but this is not enough to conclude that prehabilitation prevents it: no significant difference between the groups is reported for this outcome. A significant change in one group but not the other does not, on its own, demonstrate a difference in effectiveness.
Encouraging feasibility, still to be confirmed
Reported adherence reached 92%, and no adverse events were observed. These findings support the feasibility of the program in this sample, without establishing its safety in all situations.
With such a small sample and an assessment one week after discharge, this trial does not demonstrate a lasting recovery benefit. It primarily supports further research into preserving expiratory strength after cardiac surgery.
Limitations to keep in mind
Only the PubMed abstract was consulted, not the full text. The trial includes 36 patients, with unequal group sizes. The exact duration of the program and absolute expiratory strength results are not available in this abstract. Funding and conflicts of interest have not been verified.
What we can take away
Prehabilitation may reduce the loss of expiratory strength after scheduled cardiac surgery. This trial does not demonstrate improved functional capacity or an overall recovery benefit.
Sources and provenance
- Efficacy and feasibility of prehabilitation for cardiorespiratory functional capacity and respiratory muscle strength in cardiac surgery (PRECICA-I study).
Source date: 2026-11-20.
Journal Article, Randomized Controlled Trial · Résumé PubMed uniquement, texte intégral non consulté


